Browse All

Current Filters

CLEAR FILTER x

TITLE

Characteristics and Treatment Patterns of Patients With Myasthenia Gravis: A Retrospective, Real-world Analysis of a United States Claims Database

Author:Khan, Farid   McConnon, Aine   Sinha, Sikha   Srivastava, Riya   Heaney, Andrew   DeLasHeras, Virginia   

Session Name:P11: Neuromuscular and Clinical Neurophysiology (EMG): Myasthenia Gravis Treatments  

Topic:Neuromuscular and Clinical Neurophysiology (EMG)  

Program Number:P11.001  

Author Institution:Novartis Pharmaceuticals Corporation, East Hanover, NJ  Novartis Ireland Ltd., Dublin, Ireland  Novartis Healthcare Pvt Ltd., Hyderabad, India  Novartis Pharma AG, Basel, Switzerland  

Characteristics of a Nationwide Cohort of Patients with Developmental and Epileptic Encephalopathy Disease-causing Genotypes

Author:Nikolova, Nikol   Fisher, Carly   Riordan, Sara   Beck, Natalie   Caleshu, Colleen   

Session Name:P2: Child Neurology and Developmental Neurology: Epilepsy 1  

Topic:Child Neurology and Developmental Neurology  

Program Number:P2.002  

Author Institution:Vanderbilt University, Nashville, TN  Ohio State University, Hilliard, OH  Genome Medical, South San Francisco, CA  Genome Medical, S. San Francisco, CA  

Characteristics of Brain Structural Damage Related to Cerebral Small Vessel Disease in General Population with Intracranial Artery Stenosis

Author:Pan, Ziang   Liu, Zi-Yue   Pan, Xingqi   Yao, Ming   Zhou, Lixin   Ni, Jun   Han, Fei   Zhu, Yi-Cheng   

Session Name:P10: Cerebrovascular Disease and Interventional Neurology: Translational Science, Advanced Diagnostics, and Prediction Modeling 2  

Topic:Cerebrovascular Disease and Interventional Neurology  

Program Number:P10.006  

Author Institution:Peking Union Medical College Hospital, Chinese Academy of Medical Science, Beijing, China, People's Republic of  

Characteristics of Movement Disorders in NMOSD Patients

Author:Elkhooly, Mahmoud   Ismail, Muhammad   Bao, Fen   Bernitsas, Evanthia   

Session Name:P4: Autoimmune Neurology: NMOSD/MOGAD 4  

Topic:Autoimmune Neurology  

Program Number:P4.011  

Author Institution:Southern Illinois University School of Medicine, Springfield, IL, USA, Springfield, IL  Minia University, Minia, Egypt, Minia, Egypt  Wayne State University , Detroit, MI  Creighton University School of Medicine, Detroit, MI  

Characteristics of OFF-time Improvement in a Phase Two Study for Parkinson’s Disease (PD) with Solengepras, a Novel GPR6-inhibitor

Author:Hauser, Robert   Isaacson, Stuart   Chou, Kelvin   Sarva, Harini   Pahwa, Rajesh   Merchant, Shabbir Hussain   Brice, Nicola   Charles, Michelle   Vaidya, Sagar   Xu, Xiao   McGarry, Andrew   Leinonen, Mika   Kieburtz, Karl   Ellenbogen, Aaron   

Session Name:P8: Movement Disorders: Parkinson's Disease Emerging Therapeutics 2  

Topic:Movement Disorders  

Program Number:P8.006  

Author Institution:Parkinson’s Disease and Movement Disorders Center, Department of Neurology, University of South Florida, Tampa, FL  Parkinson's Dis & Mov Dis Ctr of Boca Raton, Boca Raton, FL  University of Michigan Health, Department of Neurology, Ann Arbor, MI  Weill Cornell Medical Center, New York, NY  University of Kansas Medical Center, Kansas City, KS  Beth Israel Deaconess Medical Center, Boston, MA  Cerevance, Cambridge, United Kingdom  Clintrex, FL  Quest Research Institute, Farmington Hills, MI